Wholesale Respiratory Devices for Colombia

Decreto 4725 (2005) is Colombia's primary regulatory framework governing the manufacturing, import, marketing, and surveillance of medical devices. It establishes the device classification system, defines registration requirements by risk class, and mandates post-market surveillance obligations for all marketed devices.

For importers, the key requirements include: submission of a tecnovigilancia (post-market surveillance) plan, adverse event reporting protocols, and periodic safety updates to INVIMA. SysMed provides the post-market surveillance documentation templates and adverse event reporting frameworks that INVIMA requires under Decreto 4725, integrated into our standard INVIMA submission packages.

The US-Colombia Trade Promotion Agreement eliminates tariffs entirely on qualifying U.S.-origin medical devices — 0% duty since the agreement took effect in 2012. Before the TPA, respiratory equipment faced import duties of 5–15% depending on HS code classification.

On a practical level: for a $50,000 wholesale ventilator order, the TPA saves $2,500–$7,500 in duties that would apply to equivalent products sourced from non-TPA countries. This makes U.S. sourcing materially cheaper on a landed-cost basis than Asian or European alternatives. SysMed provides the TPA certificate of origin with every shipment for DIAN customs clearance.

Colombia's healthcare system splits purchasing across two distinct channels. EPS (Entidades Promotoras de Salud) are insurers that manage patient enrollment and authorize treatments — they influence which devices are covered but rarely purchase equipment directly. IPS (Instituciones Prestadoras de Servicios de Salud) are the hospitals and clinics that actually buy and use the equipment.

Public-sector IPS procurement flows through institutions like the ADRES fund and territorial health entities, following formal tender processes with specific documentation timelines. Private hospital groups — Fundación Santa Fe, Clínica del Country, the Keralty network — run independent purchasing departments with shorter decision cycles. SysMed helps distributors position for both channels with appropriate pricing structures and documentation.

SysMed ships from Miami to three primary entry points, each serving different regions of Colombia:

Cartagena — Caribbean coast, fastest ocean transit at 4–6 days. Serves the northern coast and connects to Bogotá by inland transport. Buenaventura — Pacific coast port serving Cali and southern Colombian markets. Bogotá El Dorado — air freight for urgent orders, 3–7 business days.

End-to-end delivery including DIAN customs clearance typically runs 15–25 business days by sea. All shipments include commercial invoices with INVIMA registration numbers referenced, certificates of origin, and packing lists formatted for Colombian customs.

INVIMA uses a four-tier risk classification system aligned with the Global Harmonization Task Force (GHTF) framework. Most Resvent respiratory therapy equipment — CPAP, BiPAP, and portable ventilators — falls under Class IIa, which allows conditional market access while the technical file is under review. This means distributors can begin selling before full approval completes.

ICU ventilators and life-support devices classify as Class IIb or III, requiring full INVIMA technical evaluation — typically 6–8 months. SysMed holds current INVIMA registrations for the Resvent portfolio and provides the documentation package for new submissions, including the post-market surveillance plans now required under Decreto 4725.